2,287
Views
10
CrossRef citations to date
0
Altmetric
Other

Effect arylamine N-acetyltransferase 1 on morphology, adhesion, migration, and invasion of MDA-MB-231 cells: role of matrix metalloproteinases and integrin αV

ORCID Icon, ORCID Icon & ORCID Icon
Pages 1-11 | Received 08 Sep 2019, Accepted 28 Nov 2019, Published online: 07 Jan 2020

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Philip G. Board & M. W. Anders. (2021) Moonlighting in drug metabolism. Drug Metabolism Reviews 53:1, pages 76-99.
Read now

Articles from other publishers (9)

James T. F. Wise, Xinmin Yin, Xipeng Ma, Xiang Zhang & David W. Hein. (2023) Stable Isotope Tracing Reveals an Altered Fate of Glucose in N-Acetyltransferase 1 Knockout Breast Cancer Cells. Genes 14:4, pages 843.
Crossref
Courtney E. McAleese, Neville J. Butcher & Rodney F. Minchin. (2022) Arylamine N-acetyltransferase 1 deficiency inhibits drug-induced cell death in breast cancer cells: switch from cytochrome C-dependent apoptosis to necroptosis. Breast Cancer Research and Treatment 195:3, pages 223-236.
Crossref
Yuxi Cheng, Junji Ren, Shumin Fan, Peiyao Wu, Wenshu Cong, Yuxing Lin, Shaojie Lan, Siyang Song, Bin Shao, Wenbing Dai, Xueqing Wang, Hua Zhang, Bo Xu, Wenzhe Li, Xia Yuan, Bing He & Qiang Zhang. (2022) Nanoparticulates reduce tumor cell migration through affinity interactions with extracellular migrasomes and retraction fibers. Nanoscale Horizons 7:7, pages 779-789.
Crossref
Mark A. Doll, Andrew R. Ray, Raúl A. Salazar‐González, Parag P. Shah, Alexis A. Vega, Sophia M. Sears, Austin M. Krueger, Kyung U. Hong, Levi J. Beverly & David W. Hein. (2022) Deletion of arylamine N ‐acetyltransferase 1 in MDA‐MB‐231 human breast cancer cells reduces primary and secondary tumor growth in vivo with no significant effects on metastasis . Molecular Carcinogenesis 61:5, pages 481-493.
Crossref
Samantha M. Carlisle, Patrick J. Trainor, Mark A. Doll & David W. Hein. (2022) Human Arylamine N-Acetyltransferase 1 (NAT1) Knockout in MDA-MB-231 Breast Cancer Cell Lines Leads to Transcription of NAT2. Frontiers in Pharmacology 12.
Crossref
Kyung U. Hong, Jonathan Q. Gardner, Mark A. Doll, Marcus W. Stepp, Daniel W. Wilkey, Frederick W. Benz, Jian Cai, Michael L. Merchant & David W. Hein. (2022) Proteomic analysis of arylamine N-acetyltransferase 1 knockout breast cancer cells: Implications in immune evasion and mitochondrial biogenesis. Toxicology Reports 9, pages 1566-1573.
Crossref
Mohd Umar Azeem, Salman Akhtar, Mohammed Haris Siddiqui & Mohammad Kalim Ahmad Khan. (2021) Elucidation of dibenzo[a,l]pyrene and its metabolites as a mammary carcinogen: A comprehensive review. NeuroPharmac Journal, pages 204-216.
Crossref
Claudia L. Reyner, Randolph L. Winter, Kara L. Maneval, Lindsey H. Boone & Anne A. Wooldridge. (2021) Effect of recombinant equine interleukin-1β on function of equine endothelial colony-forming cells in vitro. American Journal of Veterinary Research 82:4, pages 318-325.
Crossref
Kyung U. Hong, Mark A. Doll, Angeliki Lykoudi, Raúl A. Salazar-González, Mariam R. Habil, Kennedy M. Walls, Alaa F. Bakr, Smita S. Ghare, Shirish S. Barve, Gavin E. Arteel & David W. Hein. (2020) Acetylator Genotype-Dependent Dyslipidemia in Rats Congenic for N-Acetyltransferase 2. Toxicology Reports 7, pages 1319-1330.
Crossref